Search results for " cost"
Article
ADC Development Robust Despite Lackluster Performance
Joint worldwide development costs are funded equally between the two companies, except in Japan where Takeda has full responsibility for development costs (6).
Seattle Genetics has an ADC c…
Article
Witnessing Major Growth in Next-Generation Antibodies
“With multispecific antibodies in particular,” adds de Fougerolles, “it is possible to block multiple pathways with a single molecule, which provides development cost and cost of goods advantages in a…
Article
Automating Bioprocesses
An advantage of SUS is its flexibility—modular, disposable components have a lower up-front cost compared to conventional equipment, and the systems can be more easily replicated for installation in d…
Article
Advancing Single-Use Technology Through Collaboration
Single-use systems minimize the risks for cross-contamination between batches, can be set up more quickly than traditional fixed systems, can lower operating costs per batch, and may allow for market …
Article
Process Chromatography Selection for Downstream Processing Applications
Additional factors include cost, ease of use (e.g., mixing), and disposal requirements, particularly at large scale.
Chromatography considerations
BioPharm: What are some alternatives to Pro…
Article
Continuous Processing for the Production of Biopharmaceuticals
With the growing demand for biosimilars and an ever-increasing pressure for reduction in manufacturing costs, the biotech industry seems to exhibit a flourishing interest in the development of continu…
Article
Adherent Cell Culture in Biopharmaceutical Applications: The Cell-Detachment Challenge
Production costs
Expensive cell-detachment systems negatively affect the overall cell-culture process cost and determine the applicability of the technique.
Alternative cell-detachment methods…
Article
Framing Biopharma Success in 2016
While the cost to develop an asset increased 33%, from $1.188 billion in 2010 to $1.576 billion in 2015, the average peak sales per asset dropped 50%, from $816 million in 2010 to $416 million in 2015…
Article
CMOs Continue to Improve Overall Biomanufacturing Performance
In 2015, 6 in 10 will increase spending on new technologies to improve efficiencies and costs for downstream production, for an average budget increase of 6.1%. This is likely due to new technologies …
Article
Automated harvesting and 2-step purification of unclarified mammalian cell-culture broths containing antibodies
The growth of the segment has necessitated development of new efficient and cost saving platforms for the preparation and analysis of early candidates for faster and better antibody selection and char…